Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, United States
David A Christian
Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, United States
Jodi A Gullicksrud
Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, United States
Joseph A Perry
Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, United States
Jeongho Park
Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, United States; Kangwon National University College of Veterinary Medicine and Institute of Veterinary Science, Chuncheon, Republic of Korea
Maxime Jacquet
Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, United States; Liver Immunology, Department of Biomedicine, University Hospital of Basel and University of Basel, Basel, Switzerland
James C Tarrant
Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, United States
Enrico Radaelli
Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, United States
Jonathan Silver
Department of Respiratory Inflammation and Autoimmunity, AstraZeneca, Gaithersburg, United States
IL-33 is an alarmin required for resistance to the parasite Toxoplasma gondii, but its role in innate resistance to this organism is unclear. Infection with T. gondii promotes increased stromal cell expression of IL-33, and levels of parasite replication correlate with release of IL-33 in affected tissues. In response to infection, a subset of innate lymphoid cells (ILC) emerges composed of IL-33R+ NK cells and ILC1s. In Rag1−/−mice, where NK cells and ILC1 production of IFN-γ mediate innate resistance to T. gondii, the loss of the IL-33R resulted in reduced ILC responses and increased parasite replication. Furthermore, administration of IL-33 to Rag1−/− mice resulted in a marked decrease in parasite burden, increased production of IFN-γ, and the recruitment and expansion of inflammatory monocytes associated with parasite control. These protective effects of exogenous IL-33 were dependent on endogenous IL-12p40 and the ability of IL-33 to enhance ILC production of IFN-γ. These results highlight that IL-33 synergizes with IL-12 to promote ILC-mediated resistance to T. gondii.